We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPOF icon
2326
Xponential Fitness
XPOF
$206M
$171K ﹤0.01%
13,260
ELVN icon
2327
Enliven Therapeutics
ELVN
$4.25B
$171K ﹤0.01%
12,345
EBTC
2328
DELISTED
Enterprise Bancorp
EBTC
$170K ﹤0.01%
5,265
FTI icon
2329
TechnipFMC
FTI
$30.1B
$170K ﹤0.01%
+8,424
New +$173K
CNSL
2330
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$169K ﹤0.01%
38,955
NRIM icon
2331
Northrim BanCorp
NRIM
$601M
$169K ﹤0.01%
11,844
MVST icon
2332
Microvast
MVST
$341M
$169K ﹤0.01%
120,567
+67,512
+127% +$90.6K
CRCT icon
2333
Cricut
CRCT
$1.24B
$169K ﹤0.01%
25,580
BTBT icon
2334
Bit Digital
BTBT
$520M
$168K ﹤0.01%
39,677
FLIC
2335
DELISTED
First of Long Island Corp
FLIC
$167K ﹤0.01%
12,646
XERS icon
2336
Xeris Biopharma Holdings
XERS
$1.52B
$167K ﹤0.01%
71,237
HOOD icon
2337
Robinhood
HOOD
$89.3B
$167K ﹤0.01%
13,082
-84
-0.6% -$835
FNLC icon
2338
First Bancorp
FNLC
$401M
$166K ﹤0.01%
5,900
DSGR icon
2339
Distribution Solutions Group
DSGR
$1.61B
$166K ﹤0.01%
5,266
AGS
2340
DELISTED
PlayAGS
AGS
$166K ﹤0.01%
19,713
NWPX icon
2341
NWPX Infrastructure Inc
NWPX
$1.11B
$166K ﹤0.01%
5,490
CDLX icon
2342
Cardlytics
CDLX
$25.1M
$166K ﹤0.01%
1,802
WTI icon
2343
W&T Offshore
WTI
$546M
$165K ﹤0.01%
50,704
SMMT icon
2344
Summit Therapeutics
SMMT
$11.2B
$165K ﹤0.01%
63,318
FATE icon
2345
Fate Therapeutics
FATE
$294M
$165K ﹤0.01%
44,004
GPMT
2346
Granite Point Mortgage Trust
GPMT
$58.8M
$164K ﹤0.01%
27,647
IHRT icon
2347
iHeartMedia
IHRT
$464M
$163K ﹤0.01%
61,216
BILL icon
2348
BILL Holdings
BILL
$5.11B
$163K ﹤0.01%
1,996
-38
-2% -$3.12K
FISI icon
2349
Financial Institutions
FISI
$825M
$163K ﹤0.01%
7,636
PKE icon
2350
Park Aerospace
PKE
$811M
$163K ﹤0.01%
11,062

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.